2018 Center for Biologics Evaluation and Research Science Symposium Preliminary Agenda
Preliminary Agenda
June 25, 2018
Opening Remarks
RADM Denise Hinton
Acting Chief Scientist, FDA
Session 1: Emerging and Re-Emerging Infectious Diseases
Confirmed Speakers:
Anthony Fauci, MD
Director, National Institute of Allergy and Infectious Diseases, NIH
Hira Nakhasi, MSc, PhD
Division Director & Principal Investigator, Office of Blood Research & Review, CBER, FDA
Hong Yang, PhD
Principal Investigator, Office of Biostatistics and Epidemiology, CBER, FDA
Tod Merkel, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA
Session 2: Harnessing Diverse Types of Data in Regulatory Decision-making
Confirmed Speakers:
David Madigan, PhD
Executive Vice President and Dean of Faculty of Arts and Sciences and Professor of Statistics, Columbia University
Steven Goodman, MD, MHS, PhD
Associate Dean & Professor, Stanford University
Taxiarchis Botsis, PhD
Investigator, Johns Hopkins University
Richard Forshee, PhD
Associate Director for Research, Office of Biostatistics and Epidemiology, CBER, FDA
Session 3: Immunogenicity and Immunotherapy
Confirmed Speakers:
John Tsang, PhD
Director, Computational Systems Biology, Trans-NIH Center for Human Immunology (CHI), NIAID, NIH
Carol Weiss, MD, PhD
Laboratory Chief & Principal Investigator, Office of Vaccines Research & Review, CBER, FDA
Zuben Sauna, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA
Raj Puri, MD, PhD
Division Director & Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA
June 26, 2018
Opening Remarks
Peter Marks, MD, PhD
Center Director, CBER, FDA
Session 4: New Approaches to Improve Biologics and Treatments
Confirmed Speakers:
Aviv Regev, PhD
Chair of the Faculty & Director of the Klarman Cell Observatory and Cell Circuits Program, Co-Director of the Cell Atlas Project, Broad Institute
Chava Kimchi-Sarfaty, PhD
Deputy Associate Director for Research, Office of Tissues and Advanced Therapies, CBER, FDA
Arifa Khan, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA
CD Atreya, PhD
Associate Director for Research & Principal Investigator, Office of Blood Research & Review, CBER, FDA
Historical Speaker
Lawrence Bachorik, PhD
Former FDA Associate Commissioner for Communications
Session 5: Microbiome in Human Disease
Confirmed Speakers:
Vincent Young, MD, PhD
Professor, University of Michigan
Paul Carlson, PhD
Principal Investigator, Office of Vaccines Research & Review, CBER, FDA
Vahan Simonyan, PhD
Lead Scientist, High-Performance Integrated Virtual Environment Project Director, CBER, FDA
Session 6: Advances in Regenerative Medicine
Confirmed Speakers:
Jordan Miller, PhD
Investigator, Rice University
Steven Bauer, PhD
Laboratory Chief & Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA
Malcolm Moos, MD, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA
Kyung Sung, PhD
Principal Investigator, Office of Tissues and Advanced Therapies, CBER, FDA